Remove the Plaque Buildup. Maximize Lumen Gain.

Peripheral arterial disease (PAD) is a prevalent and progressive condition that currently affects more than 12 million people in the United States.1 Our directional atherectomy (DA) devices are designed to offer minimally invasive solutions.


Directional atherectomy, with the HawkOne™ directional atherectomy system, TurboHawk™ plaque excision system, or SilverHawk™ plaque excision system, is a catheter-based, minimally invasive treatment method for PAD. During a procedure, an atherectomy catheter is directed toward an area of plaque buildup to remove the plaque from the body. A tiny directional cutting blade shaves and removes plaque from the body, allowing clinicians to maximize the lumen and restore blood flow.

Advancing PAD Treatment Through Clinical Science

The 800 patient DEFINITIVE LE study showed that the TurboHawk and SilverHawk Plaque Excision Systems provide high clinical effectiveness in a broad range of patients.2 This includes diabetics, non-diabetics, claudicants, and those with critical limb ischemia (CLI).

1 Goodney, P. P., et al. (2015). "Fifteen-year trends in lower limb amputation, revascularization, and preventive measures among medicare patients." JAMA Surg 150(1): 84-86.
2 McKinsey, J. F., et al. (2014). "Lower extremity revascularization using directional atherectomy:12-month prospective results of the DEFINITIVE LE study." JACC Cardiovasc Interv 7(8): 923-933.


UC201603770 EE